Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Buisson

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Intestinal Research|November 6, 2025
Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn's disease: results from an international surveyCharlotte Wong, Johan Burisch, Ryan C Ungaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2015
Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's diseaseAnthony Buisson, Constance Hordonneau, Marion Goutte, et al.
Therapeutic Advances in Gastroenterology|May 12, 2026
Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's diseaseParambir S Dulai, Giorgos Bamias, Vipul Jairath, et al.
World Journal of Gastroenterology|June 1, 2019
Combined evaluation of biomarkers as predictor of maintained remission in Crohn's diseaseElisa Sollelis, Régine Minet Quinard, Guillaume Bouguen, et al.
Clinics and Research in Hepatology and Gastroenterology|November 3, 2025
Diagnosis and management of patients with Crohn's disease. Position paper from the GETAIDAurélien Amiot, Anthony Buisson, Jean Marc Gornet, et al.
Best Practice & Research. Clinical Gastroenterology|August 6, 2025
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicineLéa Sequier, Bénédicte Caron, Sailish Honap, et al.
Journal of Gastroenterology and Hepatology|March 10, 2022
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's diseaseWalter Reinisch, Xavier Hébuterne, Anthony Buisson, et al.
Journal of Clinical Gastroenterology|July 21, 2017
Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel DiseasesAnthony Buisson, Emilie Vazeille, Régine Minet-Quinard, et al.
Inflammatory Bowel Diseases|February 8, 2024
Physical Activity and IBD: State of Art and Knowledge, Patients and Healthcare Professionals Points of View, A French Multicenter Cross Sectional StudyLea Derbey, Anne Laure Charlois, Anthony Buisson, et al.
Journal of Crohn'S & Colitis|April 24, 2024
Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJohn David Chetwood, Yvonne Tran, Sreedhar Subramanian, et al.
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Intestinal Research|November 6, 2025
Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn's disease: results from an international surveyCharlotte Wong, Johan Burisch, Ryan C Ungaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2015
Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's diseaseAnthony Buisson, Constance Hordonneau, Marion Goutte, et al.
Therapeutic Advances in Gastroenterology|May 12, 2026
Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's diseaseParambir S Dulai, Giorgos Bamias, Vipul Jairath, et al.
World Journal of Gastroenterology|June 1, 2019
Combined evaluation of biomarkers as predictor of maintained remission in Crohn's diseaseElisa Sollelis, Régine Minet Quinard, Guillaume Bouguen, et al.
Clinics and Research in Hepatology and Gastroenterology|November 3, 2025
Diagnosis and management of patients with Crohn's disease. Position paper from the GETAIDAurélien Amiot, Anthony Buisson, Jean Marc Gornet, et al.
Best Practice & Research. Clinical Gastroenterology|August 6, 2025
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicineLéa Sequier, Bénédicte Caron, Sailish Honap, et al.
Journal of Gastroenterology and Hepatology|March 10, 2022
Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's diseaseWalter Reinisch, Xavier Hébuterne, Anthony Buisson, et al.
Journal of Clinical Gastroenterology|July 21, 2017
Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel DiseasesAnthony Buisson, Emilie Vazeille, Régine Minet-Quinard, et al.
Inflammatory Bowel Diseases|February 8, 2024
Physical Activity and IBD: State of Art and Knowledge, Patients and Healthcare Professionals Points of View, A French Multicenter Cross Sectional StudyLea Derbey, Anne Laure Charlois, Anthony Buisson, et al.
Journal of Crohn'S & Colitis|April 24, 2024
Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJohn David Chetwood, Yvonne Tran, Sreedhar Subramanian, et al.
Pageof 17